2022-RA-645-ESGO Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers, a systemati...
2022-RA-645-ESGO Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers, a systematic review and meta-analysis
About this item
Full title
Author / Creator
Publisher
Kidlington: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
Introduction/Background BRCA1/2 pathogenic variant (PV) carriers have a high risk of breast and ovarian cancer. Contraceptives impact these risks in the general population. Among BRCA1/2-PV carriers, sufficient data and clear recommendations regarding contraceptives are lacking. We investigated how contraceptives modify breast and ovarian cancer ri...
Alternative Titles
Full title
2022-RA-645-ESGO Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers, a systematic review and meta-analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2728842302
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2728842302
Other Identifiers
ISSN
1048-891X
E-ISSN
1525-1438
DOI
10.1136/ijgc-2022-ESGO.535
